519 related articles for article (PubMed ID: 18205092)
1. Immunohistochemical analysis of VEGF-C/VEGFR-3 system and lymphatic vessel extent in normal and adenomatous human pituitary tissues.
Onofri C; Losa M; Uhl E; Stalla GK; Renner U
Exp Clin Endocrinol Diabetes; 2008 Mar; 116(3):152-7. PubMed ID: 18205092
[TBL] [Abstract][Full Text] [Related]
2. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma.
White JD; Hewett PW; Kosuge D; McCulloch T; Enholm BC; Carmichael J; Murray JC
Cancer Res; 2002 Mar; 62(6):1669-75. PubMed ID: 11912138
[TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour.
de la Torre NG; Buley I; Wass JA; Turner HE
Endocr Relat Cancer; 2006 Sep; 13(3):931-44. PubMed ID: 16954441
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
8. Expression of VEGFR-3 and 5'-nase in regenerating lymphatic vessels of the cutaneous wound healing.
Ji RC; Miura M; Qu P; Kato S
Microsc Res Tech; 2004 Jun; 64(3):279-86. PubMed ID: 15452895
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M
Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic vessels assessment in feline mammary tumours.
Sarli G; Sassi F; Brunetti B; Rizzo A; Diracca L; Benazzi C
BMC Cancer; 2007 Jan; 7():7. PubMed ID: 17222331
[TBL] [Abstract][Full Text] [Related]
11. VEGFR-3 in adult angiogenesis.
Witmer AN; van Blijswijk BC; Dai J; Hofman P; Partanen TA; Vrensen GF; Schlingemann RO
J Pathol; 2001 Nov; 195(4):490-7. PubMed ID: 11745682
[TBL] [Abstract][Full Text] [Related]
12. The lymphatic system and its specific growth factor vascular endothelial growth factor C in kidney tissue and in renal cell carcinoma.
Voss M; Steidler A; Grobholz R; Weiss C; Alken P; Michel MS; Trojan L
BJU Int; 2009 Jul; 104(1):94-9. PubMed ID: 19500329
[TBL] [Abstract][Full Text] [Related]
13. The role of the VEGF-C/VEGFR-3 axis in cancer progression.
Su JL; Yen CJ; Chen PS; Chuang SE; Hong CC; Kuo IH; Chen HY; Hung MC; Kuo ML
Br J Cancer; 2007 Feb; 96(4):541-5. PubMed ID: 17164762
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
Nishida N; Yano H; Komai K; Nishida T; Kamura T; Kojiro M
Cancer; 2004 Sep; 101(6):1364-74. PubMed ID: 15368324
[TBL] [Abstract][Full Text] [Related]
15. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of lymphangiogenesis to progression of colorectal cancer].
Wang TB; Huang YH; Lan P; Song XM; Wang JP
Ai Zheng; 2005 Oct; 24(10):1276-9. PubMed ID: 16219148
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast.
Li YS; Kaneko M; Amatya VJ; Takeshima Y; Arihiro K; Inai K
Pathol Int; 2006 May; 56(5):256-61. PubMed ID: 16669874
[TBL] [Abstract][Full Text] [Related]
19. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody.
Pytowski B; Goldman J; Persaud K; Wu Y; Witte L; Hicklin DJ; Skobe M; Boardman KC; Swartz MA
J Natl Cancer Inst; 2005 Jan; 97(1):14-21. PubMed ID: 15632376
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
